Credit score: Unsplash/CC0 Public Area A single dose of the long-acting antibody nirsevimab to infants can halve hospitalizations for bronchiolitis.…
Read More
Monoclonal antibody supplies robust real-world safety towards extreme RSV in infants, suggests meta-analysis
Credit score: Pixabay/CC0 Public Area Nirsevimab, a monoclonal antibody, is very efficient in real-world situations at stopping extreme respiratory syncytial…
Read More
